WHO ICTRP trial
Effect of PI3K/AKT signaling pathway on GABA A receptor expression, regulation…
ChiCTR2100046816 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046816 |
|---|---|
| Public title | Effect of PI3K/AKT signaling pathway on GABA A receptor expression, regulation and prognosis in small for gestational age infants with brain injury |
| Scientific title | Effect of PI3K/AKT signaling pathway on GABA A receptor expression, regulation and prognosis in small for gestational age infants with brain injury using MRI |
| Primary sponsor | Qi Ying |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | neonatal brain injury |
| Interventions | Gold Standard:Clinical data, laboratory examination and MRI results.;Index test:Cerebral blood flow, cerebral metabolic rate of oxygen, oxygen saturation fractions in venous blood. |
| Registration date | May 28, 2021 |
| Target size | Target condition:120;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: